424 related articles for article (PubMed ID: 21440336)
1. 2,3-dideoxy hex-2-enopyranosid-4-uloses as promising new anti-tubercular agents: design, synthesis, biological evaluation and SAR studies.
Saquib M; Husain I; Sharma S; Yadav G; Singh VK; Sharma SK; Shah P; Siddiqi MI; Kumar B; Lal J; Jain GK; Srivastava BS; Srivastava R; Shaw AK
Eur J Med Chem; 2011 Jun; 46(6):2217-23. PubMed ID: 21440336
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and optimization of antitubercular activities in a series of 4-(aryloxy)phenyl cyclopropyl methanols.
Bisht SS; Dwivedi N; Chaturvedi V; Anand N; Misra M; Sharma R; Kumar B; Dwivedi R; Singh S; Sinha SK; Gupta V; Mishra PR; Dwivedi AK; Tripathi RP
Eur J Med Chem; 2010 Dec; 45(12):5965-78. PubMed ID: 20970222
[TBL] [Abstract][Full Text] [Related]
3. Novel aryloxy azolyl chalcones with potent activity against Mycobacterium tuberculosis H37Rv.
Marrapu VK; Chaturvedi V; Singh S; Singh S; Sinha S; Bhandari K
Eur J Med Chem; 2011 Sep; 46(9):4302-10. PubMed ID: 21764184
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
[TBL] [Abstract][Full Text] [Related]
5. Identification, synthesis, and pharmacological evaluation of tetrahydroindazole based ligands as novel antituberculosis agents.
Guo S; Song Y; Huang Q; Yuan H; Wan B; Wang Y; He R; Beconi MG; Franzblau SG; Kozikowski AP
J Med Chem; 2010 Jan; 53(2):649-59. PubMed ID: 20000470
[TBL] [Abstract][Full Text] [Related]
6. Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines.
Protopopova M; Hanrahan C; Nikonenko B; Samala R; Chen P; Gearhart J; Einck L; Nacy CA
J Antimicrob Chemother; 2005 Nov; 56(5):968-74. PubMed ID: 16172107
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and evaluation of diarylpiperazine derivatives as potent anti-tubercular agents.
Penta A; Franzblau S; Wan B; Murugesan S
Eur J Med Chem; 2015 Nov; 105():238-44. PubMed ID: 26498570
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and anti-tubercular evaluation of new 2-acylated and 2-alkylated amino-5-(4-(benzyloxy)phenyl)thiophene-3-carboxylic acid derivatives. Part 1.
Lu X; Wan B; Franzblau SG; You Q
Eur J Med Chem; 2011 Sep; 46(9):3551-63. PubMed ID: 21641695
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological activity, and SAR of antimycobacterial 2- and 8-substituted 6-(2-furyl)-9-(p-methoxybenzyl)purines.
Braendvang M; Gundersen LL
Bioorg Med Chem; 2007 Nov; 15(22):7144-65. PubMed ID: 17804243
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of SQ109 analogues as potential anti-tuberculosis candidates.
Onajole OK; Govender P; van Helden PD; Kruger HG; Maguire GE; Wiid I; Govender T
Eur J Med Chem; 2010 May; 45(5):2075-9. PubMed ID: 20149497
[TBL] [Abstract][Full Text] [Related]
11. C-3 alkyl/arylalkyl-2,3-dideoxy hex-2-enopyranosides as antitubercular agents: synthesis, biological evaluation, and QSAR study.
Saquib M; Gupta MK; Sagar R; Prabhakar YS; Shaw AK; Kumar R; Maulik PR; Gaikwad AN; Sinha S; Srivastava AK; Chaturvedi V; Srivastava R; Srivastava BS
J Med Chem; 2007 Jun; 50(13):2942-50. PubMed ID: 17542574
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, antitubercular activity, and SAR study of N-substituted-phenylamino-5-methyl-1H-1,2,3-triazole-4-carbohydrazides.
Jordão AK; Sathler PC; Ferreira VF; Campos VR; de Souza MC; Castro HC; Lannes A; Lourenco A; Rodrigues CR; Bello ML; Lourenco MC; Carvalho GS; Almeida MC; Cunha AC
Bioorg Med Chem; 2011 Sep; 19(18):5605-11. PubMed ID: 21840219
[TBL] [Abstract][Full Text] [Related]
13. Diversity oriented design of various hydrazides and their in vitro evaluation against Mycobacterium tuberculosis H37Rv strains.
Manvar A; Bavishi A; Radadiya A; Patel J; Vora V; Dodia N; Rawal K; Shah A
Bioorg Med Chem Lett; 2011 Aug; 21(16):4728-31. PubMed ID: 21752642
[TBL] [Abstract][Full Text] [Related]
14. Discovery of new 1,3,5-triazine scaffolds with potent activity against Mycobacterium tuberculosis H37Rv.
Sunduru N; Gupta L; Chaturvedi V; Dwivedi R; Sinha S; Chauhan PM
Eur J Med Chem; 2010 Aug; 45(8):3335-45. PubMed ID: 20452706
[TBL] [Abstract][Full Text] [Related]
15. Naphthoquinones isolated from Diospyros anisandra exhibit potent activity against pan-resistant first-line drugs Mycobacterium tuberculosis strains.
Uc-Cachón AH; Borges-Argáez R; Said-Fernández S; Vargas-Villarreal J; González-Salazar F; Méndez-González M; Cáceres-Farfán M; Molina-Salinas GM
Pulm Pharmacol Ther; 2014 Feb; 27(1):114-20. PubMed ID: 23968826
[TBL] [Abstract][Full Text] [Related]
16. Anti-tubercular agents. Part 6: synthesis and antimycobacterial activity of novel arylsulfonamido conjugated oxazolidinones.
Kamal A; Shetti RV; Azeeza S; Swapna P; Khan MN; Khan IA; Sharma S; Abdullah ST
Eur J Med Chem; 2011 Mar; 46(3):893-900. PubMed ID: 21272965
[TBL] [Abstract][Full Text] [Related]
17. 3D-QSAR and molecular modeling studies on 2,3-dideoxy hexenopyranosid-4-uloses as anti-tubercular agents targeting alpha-mannosidase.
Shah P; Saquib M; Sharma S; Husain I; Sharma SK; Singh V; Srivastava R; Shaw AK; Siddiqi MI
Bioorg Chem; 2015 Apr; 59():91-6. PubMed ID: 25727263
[TBL] [Abstract][Full Text] [Related]
18. Development of antitubercular compounds based on a 4-quinolylhydrazone scaffold. Further structure-activity relationship studies.
Gemma S; Savini L; Altarelli M; Tripaldi P; Chiasserini L; Coccone SS; Kumar V; Camodeca C; Campiani G; Novellino E; Clarizio S; Delogu G; Butini S
Bioorg Med Chem; 2009 Aug; 17(16):6063-72. PubMed ID: 19620006
[TBL] [Abstract][Full Text] [Related]
19. Preliminary structure-activity relationships and biological evaluation of novel antitubercular indolecarboxamide derivatives against drug-susceptible and drug-resistant Mycobacterium tuberculosis strains.
Onajole OK; Pieroni M; Tipparaju SK; Lun S; Stec J; Chen G; Gunosewoyo H; Guo H; Ammerman NC; Bishai WR; Kozikowski AP
J Med Chem; 2013 May; 56(10):4093-103. PubMed ID: 23611124
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and pharmacological evaluation of mefloquine-based ligands as novel antituberculosis agents.
Mao J; Wang Y; Wan B; Kozikowski AP; Franzblau SG
ChemMedChem; 2007 Nov; 2(11):1624-30. PubMed ID: 17680579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
